科研成果详情

题名Innate immune responsive inflammation in development of progressive myopia
作者
发表日期2024-01-29
发表期刊EYE   影响因子和分区
语种英语
原始文献类型Article ; Early Access
其他关键词ENDOTHELIAL GROWTH-FACTOR ; BLOOD-RETINAL BARRIER ; AQUEOUS-HUMOR LEVELS ; CLINICAL-EVIDENCE ; EXPRESSION ; ICAM-1 ; DEGENERATION ; TGF-BETA-2 ; CYTOKINES ; VISION
摘要PurposeInflammation has been implicated for development of myopia. It is not clear when inflammation is kicked in during the course of myopia, and what characteristics of the inflammation. In this study, we tested for cytokines from aqueous humour of eyes with wide spectrum of refractive status for profiling the inflammation.MethodsAqueous humour of 142 patient eyes were tested for soluble intercellular adhesion molecule 1 (sICAM-1), monocyte chemoattractant protein-1 (MCP-1), and transforming growth factor-beta 2 (TGF-beta 2) using an enzyme-linked immunosorbent assay (ELISA). Eye globe axial length of these patients ranged from emmetropia to high myopia.ResultsOf 142 patients, an average axial length is 25.51 +/- 3.31 mm, with a range of 21.56-34.37 mm. There are 36 cases in lower 25 percentile, 37 cases in upper 25 percentile, and 69 case in the middle 50 percentile. sICAM-1 and MCP-1 were significantly higher in the eyes with staphyloma (407.48 pg/mL, 312.31 pg/mL, n = 33) or macular schisis (445.86 pg/mL,345.33 pg/mL, n = 19) than that in the eyes without these changes (206.44 pg/mL, 244.76 pg/mL, n = 107). All three cytokines level was significantly associated with eye globe axial in a positive mode while adjusting for the age and sex. Strength of the association was the greatest for sICAM-1 and the weakest for TGF- beta 2. MCP-1 was in between.ConclusionsICAM-1 and MCP-1 in ocular fluid may be indicative biomarkers for progressive high myopia and the underneath autoimmune inflammation. sICAM-1 may be used as a monitoring biomarker for development of pathologic myopia.
资助项目Zhejiang Health Science and Technology Program [2021PY074]; Ningbo Yinzhou District Agricultural Social Science and Technology project [2021AS0056]
出版者SPRINGERNATURE
ISSN0950-222X
EISSN1476-5454
卷号38期号:8页码:1542-1548
DOI10.1038/s41433-024-02947-z
页数7
WOS类目Ophthalmology
WOS研究方向Ophthalmology
WOS记录号WOS:001153684900002
收录类别SCIE ; PUBMED ; SCOPUS
在线发表日期2024-01
URL查看原文
PubMed ID38287111
SCOPUSEID2-s2.0-85183378347
通讯作者地址[Cheng, Lingyun]Jacob’s Retina Center at Shiley Eye Institute,Department of Ophthalmology,University of California San Diego,La Jolla,United States
Scopus学科分类Ophthalmology;Sensory Systems
引用统计
文献类型期刊论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/207061
专题其他_附属宁波市眼科医院
通讯作者Cheng, Lingyun
作者单位
1.The Affiliated Ningbo Eye Hospital of Wenzhou Medical University,Ningbo,China;
2.Department of Ophthalmology,Dongyang People’s Hospital,Dongyang,China;
3.Jacob’s Retina Center at Shiley Eye Institute,Department of Ophthalmology,University of California San Diego,La Jolla,United States
第一作者单位其他_附属宁波市眼科医院
第一作者的第一单位其他_附属宁波市眼科医院
推荐引用方式
GB/T 7714
Pan, Suqi,Yuan, Jianshu,Jin, Yuanhui,et al. Innate immune responsive inflammation in development of progressive myopia[J]. EYE,2024,38(8):1542-1548.
APA Pan, Suqi., Yuan, Jianshu., Jin, Yuanhui., Liu, Xiaotian., Wu, Shanjun., ... & Cheng, Lingyun. (2024). Innate immune responsive inflammation in development of progressive myopia. EYE, 38(8), 1542-1548.
MLA Pan, Suqi,et al."Innate immune responsive inflammation in development of progressive myopia".EYE 38.8(2024):1542-1548.

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Pan, Suqi]的文章
[Yuan, Jianshu]的文章
[Jin, Yuanhui]的文章
百度学术
百度学术中相似的文章
[Pan, Suqi]的文章
[Yuan, Jianshu]的文章
[Jin, Yuanhui]的文章
必应学术
必应学术中相似的文章
[Pan, Suqi]的文章
[Yuan, Jianshu]的文章
[Jin, Yuanhui]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。